Fennec Pharmaceuticals (FENC) Profit After Tax (2010 - 2025)
Fennec Pharmaceuticals (FENC) posted Profit After Tax of -$4.8 million for Q4 2025, down 650.31% on a QoQ basis from -$638000.0 in Q3 2025, and down 141.16% year-over-year from $11.6 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Profit After Tax (2010 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Profit After Tax history runs 16 years deep, the most recent figure standing at -$4.8 million for Q4 2025.
- Quarterly Profit After Tax fell 141.16% year-over-year to -$4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$9.7 million (down 2134.4% YoY) and the FY2025 annual result came in at -$9.7 million, down 2134.17% from the prior year.
- Profit After Tax was -$4.8 million for Q4 2025 at Fennec Pharmaceuticals, down from -$638000.0 in the prior quarter.
- Across five years, Profit After Tax topped out at $12.8 million in Q1 2024 and bottomed at -$8.0 million in Q3 2022.
- A 5-year average of -$3.3 million and a median of -$4.2 million in 2021 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 312.11% in 2024, while the deepest fall reached 207.18% in 2024.
- Fennec Pharmaceuticals' Profit After Tax stood at -$4.3 million in 2021, then slumped by 58.04% to -$6.7 million in 2022, then jumped by 60.12% to -$2.7 million in 2023, then grew by 25.99% to -$2.0 million in 2024, then tumbled by 141.16% to -$4.8 million in 2025.
- Business Quant data shows FENC's Profit After Tax at -$4.8 million in Q4 2025, -$638000.0 in Q3 2025, and -$3.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Fennec Pharmaceuticals | 287.77 Mn | 250.98 Mn | 12.01 Mn | -4.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.79 Mn |
| Sep 30, 2025 | -638,000.00 |
| Jun 30, 2025 | -3.15 Mn |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | -1.99 Mn |
| Sep 30, 2024 | -5.74 Mn |
| Jun 30, 2024 | -5.55 Mn |
| Mar 31, 2024 | 12.84 Mn |
| Dec 31, 2023 | -2.68 Mn |
| Sep 30, 2023 | -1.87 Mn |
| Jun 30, 2023 | -5.44 Mn |
| Mar 31, 2023 | -6.05 Mn |
| Dec 31, 2022 | -6.73 Mn |
| Sep 30, 2022 | -8.05 Mn |
| Jun 30, 2022 | -5.06 Mn |
| Mar 31, 2022 | -3.60 Mn |
| Dec 31, 2021 | -4.26 Mn |
| Sep 30, 2021 | -4.22 Mn |
| Jun 30, 2021 | -3.96 Mn |
| Mar 31, 2021 | -4.91 Mn |